Protai
Israel
- Tel Aviv
- 05/01/2022
- Seed
- $8,000,000
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
- Industry Biotechnology Research
- Website https://www.protai.bio/
- LinkedIn https://www.linkedin.com/company/protai-bio/about/
Related People
Eran SegerCo Founder
Israel -
Tel Aviv
My passion lays at the intersection of cutting edge technology and innovative biology. Building on over 15 years of experience in various leadership positions in the High-tech & Cyber field together with my knowledge and passion for the computational-bio space, I co-founded Protai a tech driven drug development computational biology startup.
Protai has built an end-to-end AI-based platform that comprehensively maps the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are discovered.
Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Lucis (YC X25) | $8,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)